hydroxychloroquine has been researched along with Rosacea in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moreover, the effects of HCQ treatment for rosacea patients were investigated." | 5.56 | Hydroxychloroquine is a novel therapeutic approach for rosacea. ( Deng, Z; Huang, Y; Li, J; Liu, F; Tang, Y; Wang, B; Yuan, X; Zhang, Y; Zhao, Z, 2020) |
| "Moreover, the effects of HCQ treatment for rosacea patients were investigated." | 1.56 | Hydroxychloroquine is a novel therapeutic approach for rosacea. ( Deng, Z; Huang, Y; Li, J; Liu, F; Tang, Y; Wang, B; Yuan, X; Zhang, Y; Zhao, Z, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 2 |
| Yuan, X | 2 |
| Tang, Y | 2 |
| Wang, B | 2 |
| Deng, Z | 1 |
| Huang, Y | 1 |
| Liu, F | 1 |
| Zhao, Z | 2 |
| Zhang, Y | 1 |
| Huang, X | 1 |
| Yang, B | 2 |
| Zheng, Y | 1 |
| Yuan, C | 1 |
| Xie, H | 1 |
| Marzano, AV | 1 |
| Lazzari, R | 1 |
| Polloni, I | 1 |
| Boneschi, V | 1 |
| Crosti, C | 1 |
| FREDRIKSSON, T | 1 |
| LODIN, A | 1 |
| ROSENGREN, S | 1 |
1 trial available for hydroxychloroquine and Rosacea
| Article | Year |
|---|---|
Efficacy and safety of hydroxychloroquine for treatment of patients with rosacea: A multicenter, randomized, double-blind, double-dummy, pilot study.
Topics: Adult; Double-Blind Method; Doxycycline; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pilo | 2021 |
3 other studies available for hydroxychloroquine and Rosacea
| Article | Year |
|---|---|
Hydroxychloroquine is a novel therapeutic approach for rosacea.
Topics: Animals; Anti-Inflammatory Agents; Calcium Signaling; Cells, Cultured; Cytokines; Disease Models, An | 2020 |
Rosacea-like cutaneous lupus erythematosus: an atypical presentation responding to antimalarials.
Topics: Adult; Aged; Antimalarials; Diagnosis, Differential; Erythema; Female; Humans; Hydroxychloroquine; L | 2013 |
[Treatment of discoid lupus erythematosus, polymorphous photodermatosis and rosacea with Triquin--a combination of 3 anti-malarials].
Topics: Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythema | 1962 |